Skip to main content

Read the latest news about the use of biomarkers in research on Alzheimer's prevention.

31 May | 2023

We use artificial intelligence to validate a new biomarker of brain aging

The data have been compared with Alzheimer's biomarkers of 2,300 people from four cohorts, including participants without cognitive alterations from the ALFA Study, promoted by the ”la Caixa” Foundation.

22 May | 2023

Biomarkers in blood lead the way to the future of Alzheimer's research

More than 80 researchers have attended the Biomarkers Workshop, a scientific event with great international impact, organised by the Barcelonaβeta Brain Research Center.

13 Mar | 2023

The BBRC hosts the sixth edition of the Workshop on biomarkers for neurodegenerative diseases

The event, organized together with University College London and the University of Gothenburg, is aimed at PhD students and will take place between the 15th and the 19th of May.

16 Nov | 2022

The validity of nine biomarkers for diagnosing Alzheimer's disease in daily clinical practice has been determined

A study led by the Hospital del Mar Medical Research Institute, the Barcelonaβeta Brain Research Centre and the University of Gothenburg has compared the validity of nine biomarkers for the day-to-day diagnosis of Alzheimer's disease in hospital centres.

11 Aug | 2022

A new study identifies two biomarkers in the blood that better capture early signs of Alzheimer's

The study, which used data from almost 400 participants of the ALFA+ Study, determines that the biomarkers p-tau231 and p-tau217 measured in the blood are suitable for indicating brain changes related to the amyloid protein in people without cognitive symptoms.

23 Jul | 2021

The project on artificial intelligence algorithms in magnetic resonance obtains a 'Digital EIT 2021'

The organization under the European Commission will finance part of the project

04 Sep | 2020

Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

07 Aug | 2020

BBRC presents more than 20 studies at the Alzheimer's Association International Conference 2020

The most prominent congress dedicated to Alzheimer's research has been held completely virtual

03 Aug | 2020

Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy